Hyloris Pushes Into South America With Maxigesic IV
Extends Existing Alliance With Pharma Bavaria To Cover 17 Countries
Hyloris is on a roll with licensing deals for its Maxigesic IV non-opioid pain treatment, with an extension of its existing agreement with Pharma Bavaria to cover South American territories coming hot on the heels of recent developments in the US and Europe.
